Severe hydroxychloroquine myopathy

Muscle & Nerve
Hoda Abdel-HamidDavid Lacomis

Abstract

Hydroxychloroquine causes a vacuolar myopathy that is usually of mild to moderate severity. The myopathy may be underrecognized, especially in patients who receive multiple other medications for complex illnesses. We report two patients with connective tissue diseases and unusually severe, histopathologically proven hydroxychloroquine myopathy. Both had ventilatory failure; one also had primary pulmonary disease associated with scleroderma, but the other lacked a pulmonary etiology. The ventilatory failure and subsequent medical complications led to death despite discontinuation of hydroxychloroquine, thereby underscoring the potential severity of hydroxychloroquine myopathy and the need for its early recognition.

References

Mar 1, 1987·The American Journal of Medicine·M L EstesN B Ratliff
Jul 18, 1983·The American Journal of Medicine·E W McChesney
Feb 14, 2007·Chest·Anita K SiddiquiLinda S Efferen

❮ Previous
Next ❯

Citations

Mar 1, 2012·Journal of Clinical Neuromuscular Disease·David Lacomis
Jul 20, 2014·Neurologic Clinics·Mamatha PasnoorMazen M Dimachkie
Jun 29, 2010·Current Opinion in Neurology·Frank L Mastaglia
May 3, 2013·Immunopharmacology and Immunotoxicology·Ernst TönnesmannThorsten Lewalter
May 22, 2013·The Psychiatric Clinics of North America·Hani A Kushlaf
Nov 28, 2012·Physical Medicine and Rehabilitation Clinics of North America·Michael K Hehir, Eric L Logigian
Dec 27, 2011·Reumatología clinica·Gerardo Gutiérrez-GutiérrezAmbrosio Miralles Martínez
Aug 2, 2011·Neurologic Clinics·Hani A Kushlaf
Aug 10, 2010·Clinics in Chest Medicine·Danielle Antin-OzerkisRichard A Matthay
Nov 5, 2013·Autophagy·James K ChingConrad C Weihl
Dec 7, 2016·Continuum : Lifelong Learning in Neurology·Hans D Katzberg, Charles D Kassardjian
Feb 9, 2011·Lupus·C PosadaS Teijeira
Aug 7, 2018·Current Opinion in Neurology·Mamatha PasnoorMazen M Dimachkie
Nov 10, 2018·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Shaweta KhosaShri K Mishra
Nov 7, 2009·The Journal of Rheumatology·Timothy A LoneskyC Harker Rhodes
Dec 4, 2019·Continuum : Lifelong Learning in Neurology·Christopher T Doughty, Anthony A Amato
Feb 9, 2020·Nature Reviews. Rheumatology·Eva Schrezenmeier, Thomas Dörner
Jan 12, 2021·Journal of Chemotherapy·Muhammad Sani IsmailaKarla Georges
Nov 10, 2020·Current Pharmacology Reports·Alzira Alves de Siqueira Carvalho
Dec 24, 2020·Internal Medicine Journal·Roger PamphlettRenee Cf Chan
Feb 23, 2021·Frontiers in Molecular Biosciences·Rajashri R Naik, Ashok K Shakya
Feb 20, 2021·Frontiers in Neurology·Elie NaddafOmar F AbouEzzeddine
Dec 17, 2009·Current Opinion in Rheumatology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.